Cell-Based Assays to Play Role in $1.5M Award From Fox Foundation for Parkinson s Research | GenomeWeb

The Michael J. Fox Foundation for Parkinson’s Research has created a drug-discovery and -development program to address gaps in Parkinson’s disease research, and speed therapies to market, the group said last week.

The first initiative will provide $1.5 million in funding for Parkinson’s target validation research, MJFF said.

Although a variety of techniques are used in the target validation process, cell-based and small-animal in vivo assays are high on the list.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.